Intensity modulated radiotherapy (IMRT) in benign giant cell tumors

• Verfasst von: Röder, Falk [VerfasserIn]
• Verfasst von: Timke, Carmen [VerfasserIn]
• Verfasst von: Zwicker, Felix [VerfasserIn]
• Verfasst von: Thieke, Christian [VerfasserIn]
• Verfasst von: Bischof, Marc [VerfasserIn]
• Verfasst von: Debus, Jürgen [VerfasserIn]
• Verfasst von: Huber, Peter E. [VerfasserIn]
• Titel: Intensity modulated radiotherapy (IMRT) in benign giant cell tumors
• Titelzusatz: a single institution case series and a short review of the literature
• Verf.angabe: Falk Roeder, Carmen Timke, Felix Zwicker, Christian Thieke, Marc Bischof, Jürgen Debus, Peter E Huber
• E-Jahr: 2010
• Jahr: 26 February 2010
• Umfang: 7 S.
• Fussnoten: Gesehen am 14.06.2023
• Titel Quelle: Enthalten in: Radiation oncology
• Ort Quelle: London : BioMed Central, 2006
• Jahr Quelle: 2010
• Band/Heft Quelle: 5(2010), Artikel-ID 18, Seite 1-7
• ISSN Quelle: 1748-717X
• DOI: doi:10.1186/1748-717X-5-18
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Chordoma
• Sach-SW: Clinical Target Volume
• Sach-SW: Denosumab
• Sach-SW: Giant Cell Tumor
• Sach-SW: Local Control Rate
• K10plus-PPN: 184895560X

Abstract

Giant cell tumors are rare neoplasms, representing less than 5% of all bone tumors. The vast majority of giant cell tumors occurs in extremity sites and is treated by surgery alone. However, a small percentage occurs in pelvis, spine or skull bones, where complete resection is challenging. Radiation therapy seems to be an option in these patients, despite the lack of a generally accepted dose or fractionation concept. Here we present a series of five cases treated with high dose IMRT.